Li et al. demonstrated that ILA derived from Bifidobacterium breve promotes AKT phosphorylation, inhibits M1 macrophage polarization, alleviates colitis, and suppresses tumorigenesis [37]. This evidence concerns the gene TNFRSF9 and colitis.